Terbutaline Sulfate Tablet
Product Images NDC 0115-2622

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Terbutaline Sulfate (NDC 0115-2622). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Of New York Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (Terbutaline Sulfate Tablets Usp 1)

FDA Label Image

1 (Terbutaline Sulfate Tablets Usp 2)

FDA Label Image

1 (Terbutaline Sulfate Tablets Usp 3)

1 (Terbutaline Sulfate Tablets Usp 3)
This is a description of the Terbutaline Sulfate medication, with information related to the dose, storage, and safety precautions. The medication comes in tablet form, with each tablet containing 5 mg of the active ingredient. The recommended dosage information can be found in the accompanying outsert. The medication should be stored in a tightly-closed, light-resistant container with a child-resistant closure. It should not be used if the safety seal under the cap is broken or missing. The medication should be kept out of the reach of children. The manufacturer of the medication is Amneal Pharmaceuticals Pvt Ltd, located in Ahmedabad, India. The medication is distributed by Amneal Pharmaceuticals LLC in Bridgewater, NJ.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.